RMMS Secures Favorable Claim Construction Ruling In Suit Involving Generic Aripiprazole (Abilify®) -
RMMS Recognized as Industry Leaders by LMG Life Sciences for Fourth Consecutive Year -
RMMS Secures Summary Judgment Against Otsuka Related To Generic Aripiprazole (Abilify®) -
Federal Circuit Affirms Judgment of Invalidity Concerning Pulmicort Respules® (budesonide inhalation suspension) -
RMMS Secures Second Victory Against Otsuka Related To Generic Aripiprazole (Abilify®) -
Chief Judge Simandle Allows Launch of Generic Aripiprazole (Abilify®) -
Federal Circuit Affirms Invalidity Judgment Concerning Zymaxid®/Zymar® (Gatifloxacin) Ophthalmic Solutions -
RMMS Files Supreme Court Amicus Brief on Behalf of GPhA Supporting Specific-Intent-to-Infringe Requirement for Induced Infringement -
RMMS Secures Judgment of Patent Invalidity Following Remand Trial Involving Generic Pulmicort Respules® (Budesonide Inhalation Suspension) -
Federal Circuit Affirms Judgment Of Non-Infringement Involving Generic Trizivir® (Abacavir Sulfate, Lamivudine, and Zidovudine) Tablets -